Physician

Christine Lynn Karle, D.O.

According to 2025 Medicare claims, Christine Karle, D.O. (NPI: 1669436531) practices general practice in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is KARLE MEDICAL GROUP, P.C. (NPI: 1932298379; TIN: 202484898) and primary practice location at 48307-4774. Karle is affiliated with the Senior Health Connect ACO 9 (ACO ID: A5387), participating under the MSSP model.

Karle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 134 traditional Medicare patients, billed 758 HCPCS/CPT codes, and received $47,935 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 398 prescription claims across 56 beneficiaries totaling $13,314 in drug costs, led by Rosuvastatin Calcium (Rosuvastatin Calcium). 2023 DME data shows 162 claims. Open Payments data shows 1 records totaling $18. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $81,210 to $47,935. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $204,021 to $13,314. For DME billing, reported payments moved sharply higher in recent years, from $2,442 to $13,976.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	384	2,229	$81,210
2016	346	2,214	$85,031
2017	326	1,984	$77,845
2018	320	1,978	$81,245
2019	361	1,659	$84,484
2020	296	1,188	$71,131
2021	255	1,092	$85,067
2022	185	609	$45,463
2023	138	605	$46,636
2024	134	758	$47,935

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	275	3,024	$204,021
2016	200	1,927	$118,498
2017	152	1,303	$57,687
2018	141	1,386	$65,242
2019	125	1,052	$57,009
2020	93	760	$36,162
2021	77	684	$29,727
2022	74	560	$34,335
2023	63	407	$20,332
2024	56	398	$13,314

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	18	107	$3,359
2016	13	58	$827
2017	N/R	11	$343
2018	N/R	14	$496
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	162	162	$1,278,403
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	58	58	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	108	277	$90
G0008	Administration of influenza virus vaccine	50	51	$33
G0444	Annual depression screening, 5 to 15 minutes	57	57	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	85	158	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rosuvastatin Calcium	Rosuvastatin Calcium	37	3,090	$623
Simvastatin	Simvastatin	32	2,447	$332
Metoprolol Succinate	Metoprolol Succinate	20	1,810	$245
Amlodipine Besylate	Amlodipine Besylate	27	2,430	$227
Omeprazole	Omeprazole	15	1,350	$220

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$18	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christine Lynn Karle, D.O.?

Tedicare shows public-source Medicare data for Christine Lynn Karle, D.O. (NPI 1669436531), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christine Lynn Karle, D.O. have ACO affiliation data?

Christine Lynn Karle, D.O. is shown with ACO affiliation data for Senior Health Connect ACO 9 (MSSP, ACO ID A5387).

What billing organization is linked to Christine Lynn Karle, D.O.?

Christine Lynn Karle, D.O. is linked to KARLE MEDICAL GROUP, P.C. (billing NPI 1932298379) in the available physician profile data.

Does Christine Lynn Karle, D.O. have Open Payments data?

Christine Lynn Karle, D.O. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.